Evidence map›Paper›PMID 31163974›Full record

ArticleCirculation. Heart failure2019

Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.

Veena S Rao, Tariq Ahmad, Meredith A Brisco-Bacik, Joseph V Bonventre, F Perry Wilson, Edward D Siew, G Michael Felker, Kevin K Anstrom, Devin D Mahoney, Bradley A Bart and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Heart failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Right Heart Function in Cardiorenal Syndrome.Current heart failure reports · 2022
    Pooled it
  2. Ultrafiltration for acute heart failure.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Trial
  4. Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Trial
  5. Trial
  6. Review
  7. Review
  8. Probing the Limits of Permissive Hypercreatininemia during Decongestion in Patients with Heart Failure.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Acute kidney injury in acute heart failure-when to worry and when not to worry?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. How to interpret serum creatinine increases during decongestion.Frontiers in cardiovascular medicine · 2022
    Review
  20. Inpatient Diuretic Management of Acute Heart Failure: A Practical Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Veena S RaoSections of Cardiovascular Medicine (V.S.R., T.A., D.D.M., E.J.V., J.M.T.), Yale University School of Medicine, New Haven, CT.
Tariq AhmadSections of Cardiovascular Medicine (V.S.R., T.A., D.D.M., E.J.V., J.M.T.), Yale University School of Medicine, New Haven, CT.
Meredith A Brisco-BacikCardiology Division, Lewis Katz School of Medicine at Temple University, Philadelphia, PA (M.A.B.-B.).
Joseph V BonventreDivision of Renal Medicine, Brigham and Women's Hospital, Boston. MA (J.V.B.).
F Perry WilsonNephrology (F.P.W.), Yale University School of Medicine, New Haven, CT.
Edward D SiewDivision of Nephrology and Hypertension, Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for AKI (VIP-AKI), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (E.D.S.).
G Michael FelkerDuke University Medical Center and Duke Clinical Research Institute, Durham, NC (G.M.F., K.K.A.).
Kevin K AnstromDuke University Medical Center and Duke Clinical Research Institute, Durham, NC (G.M.F., K.K.A.).
Devin D MahoneySections of Cardiovascular Medicine (V.S.R., T.A., D.D.M., E.J.V., J.M.T.), Yale University School of Medicine, New Haven, CT.
Bradley A BartDivision of Cardiology, Hennepin County Medical Center, Minneapolis, MN (B.A.B.).
W H Wilson TangSection of Heart Failure and Cardiac Transplantation, Cleveland Clinic, OH (W.H.W.T.).
Eric J VelazquezSections of Cardiovascular Medicine (V.S.R., T.A., D.D.M., E.J.V., J.M.T.), Yale University School of Medicine, New Haven, CT.
Jeffrey M TestaniSections of Cardiovascular Medicine (V.S.R., T.A., D.D.M., E.J.V., J.M.T.), Yale University School of Medicine, New Haven, CT.
Yale University · USDuke Medical Center · USBrigham and Women's Hospital · USCleveland Clinic · USHennepin County Medical Center · USTemple University · USVanderbilt University Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Mechanisms of Ischemic Kidney Injury and RepairR01DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSEPH VINCENT BONVENTRE · 1987 to 2026
$6.2M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart FailureR01HL139629 · NHLBI · YALE UNIVERSITY · PI JEFFREY M TESTANI · 2018 to 2026
$5.0M
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureR01HL128973 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2015 to 2019
$3.8M
Optimizing Electronic Alerts for Acute Kidney InjuryR01DK113191 · NIDDK · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2018 to 2022
$3.1M
Mediators & prognostic value of muscle mass & function in chronic kidney diseaseK23DK097201 · NIDDK · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2013 to 2017
$916k
Cardio-renal phenotype and prognosis in chronic heart failureK23HL114868 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2012 to 2017
$845k
Determining Mechanisms of Renal Dysfunction after Left Ventricular Assist DeviceK23HL128933 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI BRISCO-BACIK, MEREDITH ANN · 2015 to 2019
$831k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K23 HL114868NHLBI NIH HHS K23 HL128933NHLBI NIH HHS L30 HL115790NHLBI NIH HHS R01 HL128973NHLBI NIH HHS R01 HL139629NIDDK NIH HHS K23 DK097201NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK039773NIDDK NIH HHS R01 DK072381NIDDK NIH HHS R01 DK113191NIDDK NIH HHS R37 DK039773
6 · The paper itself

Abstract

Background The relationship between intensive volume removal in acute decompensated heart failure patients with preexisting worsening renal function (WRF) and renal tubular injury, postdischarge renal function, and clinical outcomes is unknown. Methods and Results We used data from the multicenter CARRESS-HF trial (Cardiorenal Rescue Study in Acute Decompensated Heart Failure) that randomized patients with acute decompensated heart failure and preexisting WRF to intensive volume removal with stepped pharmacological therapy or fixed rate ultrafiltration. Patients in the urinary renal tubular injury biomarker substudy (NAG [N-acetyl-b-D-glucosaminidase], KIM-1 [kidney injury molecule-1], and NGAL [neutrophil gelatinase-associated lipocalin]) were evaluated (N=105). The severity of prerandomization WRF was unrelated to baseline renal tubular injury biomarkers ( r=0.14; P=0.17). During randomized intensive volume removal, creatinine further worsened in 53% of patients. Despite a small to moderate magnitude increase in creatinine in most of these patients, postrandomization WRF was strongly associated with worsening in renal tubular injury biomarkers (odds ratio, 12.6; P=0.004). This observation did not differ by mode of volume removal (stepped pharmacological therapy versus ultrafiltration, P

Indexed as

AgedAged, 80 and overBiomarkersCreatinineFemaleHeart FailureHumansKidneyLipocalin-2MaleMiddle AgedProspective StudiesBiomarkersCreatinineLipocalin-2biomarkersheart failureincidencekidneyultrafiltration

Identifiers

PMID31163974
PMCPMC6585463
OpenAlexW2949823666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.